...
首页> 外文期刊>Obstetrical and gynecological survey >Gonadotrophins Versus Clomifene Citrate With or Without Intrauterine Insemination in Women With Normogonadotropic Anovulation and Clomifene Failure (M-OVIN): A Randomized, Two-by-Two Factorial Trial EDITORIAL COMMENT
【24h】

Gonadotrophins Versus Clomifene Citrate With or Without Intrauterine Insemination in Women With Normogonadotropic Anovulation and Clomifene Failure (M-OVIN): A Randomized, Two-by-Two Factorial Trial EDITORIAL COMMENT

机译:促性腺激素与克罗米蛋白柠檬酸盐有或没有胎儿嗜酸剂患者的患者患有或没有宫内生精,具有正常数系和克罗米蛋白衰竭(M-Ovin):随机,双重阶级审判编辑评论

获取原文
获取原文并翻译 | 示例
           

摘要

Clomifene citrate has long been used as a first-line ovulation induction agent for women wishing to conceive who have normogonadotropic anovulation (absent or irregular ovulation). Women who ovulate but do not conceive after several cycles with clomifene citrate are usually switched to ovulation induction with gonadotrophins, with or without intrauterine insemination. However, no randomized clinical trials have investigated the effectiveness of a switch to gonadotrophins and intrauterine insemination compared with continued treatment with clomifene citrate.
机译:Clomifene柠檬酸盐长期被用作一线排卵诱导剂,供妇女想要设想患有Normogonootropic Anovion(不存在或不规则排卵)。 排卵但在克隆丙烯酸丁酸酯的几个周期后,妇女通常用促性营养蛋白切换到排卵诱导,有或没有宫内节制蛋白。 然而,与氯簇柠檬酸酯继续处理相比,没有随机临床试验研究了转换与促毒素和宫内生精的有效性。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号